Holen Sie sich die Stockscreener-App
20.46
0.05%
0.01
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Doximity (DOCS) CFO discloses 501,549 shares, including 499,722 RSUs, on Form 3 - Stock Titan
Doximity (DOCS) President Steven Zatz receives 55,524 restricted stock units - Stock Titan
Doximity (NYSE: DOCS) president discloses 822 Class A shares - Stock Titan
Doximity Inc (DOCS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Doximity Inc (DOCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Doximity Inc (DOCS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Doximity Inc (DOCS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Doximity Inc (DOCS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Doximity Inc (DOCS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Doximity Inc (DOCS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Doximity Inc (DOCS) Institutional Confidence - TradingKey
Doximity (DOCS) Advances While Market Declines: Some Information for Investors - Yahoo Finance Singapore
Doximity, Inc. (DOCS) Stock Analysis: Exploring a 26.85% Potential Upside in Health Information Services - DirectorsTalk Interviews
Responsive Playbooks and the DOCS Inflection - Stock Traders Daily
Y Intercept Hong Kong Ltd Invests $9 Million in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Shares Purchased by Rhenman & Partners Asset Management AB - MarketBeat
Doximity (DOCS) up 11.2% since last earnings report: Can it continue? - MSN
Doximity: Cheaper, But Growth Is Still Missing (NYSE:DOCS) - Seeking Alpha
Is Doximity Struggling After Revenue Miss? - Kalkine Media
Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance Australia
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Doximity (DOCS) and Axsome Therapeutics (AXSM) - The Globe and Mail
Doximity (DOCS) Institutional Ownership 2026 $DOCS - MarketBeat
DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Inv - GuruFocus
DOCS Investors Have Opportunity to Join Doximity, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc.DOCS - PR Newswire
Doximity interim PAO Sitaram Siddharth sells $49,882 in shares By Investing.com - Investing.com Canada
Doximity interim PAO Sitaram Siddharth sells $49,882 in shares - Investing.com UK
symbol__ Stock Quote Price and Forecast - CNN
Doximity (DOCS) interim PAO trades shares under 10b5-1 plan, exercises options - Stock Titan
AI Margin Pressure And Legal Probe Might Change The Case For Investing In Doximity (DOCS) - simplywall.st
Doximity hits an all-time low after Q4 results; KeyBanc downgrades - MSN
[144] Doximity, Inc. SEC Filing - Stock Titan
Capital World Investors Has $250.40 Million Holdings in Doximity, Inc. $DOCS - MarketBeat
DOCS (NASDAQ: DOCS) Form 144 reports 2,444-share sale via exercise - Stock Titan
Doximity shares drop 23% after missing revenue targets and AI investment warning - Pluang
Doximity, Inc. (DOCS) Stock Analysis: Exploring a 22.15% Potential Upside in the Healthcare Information Sector - DirectorsTalk Interviews
Doximity(DOCS) Stock Options Chain | Quotes & News - Moomoo
Law firm investigates Doximity officers for possible shareholder rights breaches - Pluang
BofA Securities Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $38 - Moomoo
DOCS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
2026-06-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Doximity, Inc. (DOCS) and Encourages Shareholders to Learn More About the Investigation | NYSE:DOCS | Press Release - Stockhouse
Doximity stock falls on Q4 earnings miss, revenues beat, margins down - MSN
Legal & General Group Plc Sells 54,024 Shares of Doximity, Inc. $DOCS - MarketBeat
BNP Paribas Financial Markets Raises Position in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. (DOCS) Investigation: Bronstein, Gewirtz & Grossma - The National Law Review
Doximity, Inc. (DOCS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Doximity (NYSE:DOCS) Downgraded by Zacks Research to Strong Sell - MarketBeat
Workday and Doximity shares are soaring, what you need to know - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Doximity, Inc. (DOCS) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Understanding the Setup: (DOCS) and Scalable Risk - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Encourages Doximity, Inc. (DOC - The National Law Review
Assessing Doximity (DOCS) Valuation After A Year Of Weak Share Price Performance - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Doximity, Inc. (DOCS) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Doximity, Inc. (DOCS) And Encourages Shareholders to Connect - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Doximity, Inc. (DOCS) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Doximity, Inc. (DOCS) Stock Analysis: Evaluating The 17.52% Upside Potential For Investors - DirectorsTalk Interviews
DOCS Stock Price, Quote & Chart | DOXIMITY INC-CLASS A (NYSE:DOCS) - ChartMill
Doximity (DOCS) Stock Trends and Sentiment 2026 $DOCS - MarketBeat
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale? - AOL.com
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):